Глобальная карта > Инновации > North America and Caribbean > United States > Houston > Pharm-Olam
Pharm-Olam icon
Pharm-Olam was selected by the US Department of Defense to run a mid-to late-stage trial of blockbuster autoimmune and inflammation drug adalimumab, knonw as AbbVie’s Humira.
Rankings by SemRush
Национальный рейтинг
454th
in United States
Региональный рейтинг
515th
in North America and Caribbean
Глобальный рейтинг
1245th
worldwide
Loading startups...